Category: us corporate news

us corporate news

U.S. GoldMining Files PEA for Whistler Project, Alaska: $2B NPV, 33% IRR, Strong Gold-Copper Growth Potential

Minichart

March 23, 2026

U.S. GoldMining Inc. Files PEA Technical Report for Whistler...

Continue Reading 0

us corporate news

Cardinal Health, Inc. Files Form 8-K with SEC Detailing Company Information and NYSE Listing

Minichart

March 23, 2026

Cardinal Health, Inc. (CAH) Files 8-K: Board Change and Earn...

Continue Reading 0

us corporate news

Sealed Air Receives Regulatory Approvals for CD&R Acquisition, Set to Go Private in April 202

Minichart

March 23, 2026

Sealed Air Corporation Receives Final Regulatory Approvals f...

Continue Reading 0

us corporate news

YHN Acquisition I Limited Extends Business Combination Deadline with $150,000 Trust Deposit – SEC Form 8-K Filing March 2026

Minichart

March 23, 2026

YHN Acquisition I Limited Extends Deadline for Business Comb...

Continue Reading 0

us corporate news

A Paradise Acquisition Corp PFIC Annual Statement 2025: QEF Election and Tax Information for U.S. Shareholders

Minichart

March 23, 2026

A Paradise Acquisition Corp. PFIC Annual Statement: Key High...

Continue Reading 0

us corporate news

Insmed Announces Positive Phase 3b ENCORE Results for ARIKAYCE in MAC Lung Disease, Plans FDA Supplemental NDA Filing in 2026

Minichart

March 23, 2026

Insmed Announces Positive Phase 3b ENCORE Study Results for ...

Continue Reading 0

us corporate news

Coeur Mining Announces 2026 Guidance, Expands Capital Return Program After New Gold Acquisition

Minichart

March 23, 2026

Coeur Mining Provides Major Update Post-New Gold Acquisition...

Continue Reading 0

us corporate news

RenovoRx Secures $10 Million Oversubscribed Private Placement to Accelerate RenovoCath Commercialization and Advance Phase III Pancreatic Cancer Trial

Minichart

March 23, 2026

RenovoRx Announces \$10 Million Oversubscribed Private Place...

Continue Reading 0

us corporate news

Avalo Therapeutics Reports 2025 Financial Results and Prepares for Key Phase 2 LOTUS Trial Data of AVTX-009 in Hidradenitis Suppurativa

Minichart

March 23, 2026

Avalo Therapeutics Reports 2025 Financial Results and Busine...

Continue Reading 0

us corporate news

Pyxis Oncology Reports 2025 Financial Results, Advances MICVO Cancer Trials, and Announces New Leadership

Minichart

March 23, 2026

Pyxis Oncology Reports Q4 and Full-Year 2025 Results, Provid...

Continue Reading 0